Skip to main content
Search
Explore journals
Get published
About BMC
My account
Search all BMC articles
Search
Annals of General Psychiatry
Home
About
Articles
Submission Guidelines
Table 1 AChEI agents approved by the FDA: prescription share and prescription volume
From:
Current pharmacologic options for patients with Alzheimer's disease
Agent for AD Treatment
Prescription Share
Prescription Volume
Tacrine
< 1%
–
Donepezil
~66%
~530,000
Rivastigmine
~20%
~160,000
Galantamine
~14%
~110,000
Back to article page